CDCA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.815600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.976400E-01
Normal-vs-Stage2
3.463000E-01
Normal-vs-Stage3
5.985200E-01
Normal-vs-Stage4
6.421000E-01
Stage1-vs-Stage2
3.379200E-01
Stage1-vs-Stage3
8.964800E-01
Stage1-vs-Stage4
8.634000E-01
Stage2-vs-Stage3
4.893200E-01
Stage2-vs-Stage4
5.199200E-01
Stage3-vs-Stage4
9.576600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.932000E-01
Normal-vs-AfricanAmerican
4.841400E-01
Normal-vs-Asian
1.562160E-01
Caucasian-vs-AfricanAmerican
7.969000E-01
Caucasian-vs-Asian
9.208600E-01
AfricanAmerican-vs-Asian
7.131600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.923000E-01
Normal-vs-Female
4.232400E-01
Male-vs-Female
3.388800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.503800E-01
Normal-vs-Age(41-60Yrs)
4.182000E-01
Normal-vs-Age(61-80Yrs)
3.021600E-01
Normal-vs-Age(81-100Yrs)
2.143800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.381400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.802980E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.432820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.981020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.529400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.406600E-01
Normal-vs-Daily Drinker
2.272400E-01
Normal-vs-Weekly Drinker
5.074800E-01
Normal-vs-Occasional Drinker
2.155600E-01
Normal-vs-Social Drinker
2.945600E-01
Non Drinker-vs-Daily Drinker
2.609000E-01
Non Drinker-vs-Weekly Drinker
3.952200E-01
Non Drinker-vs-Occasional Drinker
5.051600E-01
Non Drinker-vs-Social Drinker
6.985000E-01
Daily Drinker-vs-Weekly Drinker
6.614000E-01
Daily Drinker-vs-Occasional Drinker
6.513000E-01
Daily Drinker-vs-Social Drinker
5.314400E-01
Weekly Drinker-vs-Occasional Drinker
5.377600E-01
Weekly Drinker-vs-Social Drinker
4.859600E-01
Occasional Drinker-vs-Social Drinker
8.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.360400E-01
Normal-vs-Grade 2
5.696600E-01
Normal-vs-Grade 3
5.886600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.048200E-04
Grade 1-vs-Grade 3
3.90289999999682E-05
Grade 1-vs-Grade 4
5.360400E-01
Grade 2-vs-Grade 3
9.453900E-02
Grade 2-vs-Grade 4
5.696600E-01
Grade 3-vs-Grade 4
5.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.113800E-01
Normal-vs-NonDiabetic
3.859800E-01
Diabetic-vs-NonDiabetic
3.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.092300E-02
Normal-vs-NoPancreatitis
4.467400E-01
Pancreatitis-vs-NoPancreatitis
9.554200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.426000E-01
Normal-vs-N1
3.920000E-01
N0-vs-N1
5.112200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.208990E-01
Normal-vs-TP53-NonMutant
4.153600E-01
TP53-Mutant-vs-TP53-NonMutant
7.68229999947856E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
